Koyfin Home > Directory > Health Care > Abiomed Inc > Cash Flow from Operations

Abiomed Inc Cash Flow from Operations Chart (ABMD)

Abiomed Inc annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Abiomed Inc Cash Flow from Operations for the quarter ending September 09, 2020 was $77m a -15.84% decrease of -12m year over year
  • Abiomed Inc Cash Flow from Operations for the last 12 months ending September 09, 2020 was $285m a -4.81% decrease of -14m year over year
  • Abiomed Inc Annual Cash Flow from Operations for 2020 was $315m a 19.92% increase of 63m from 2019
  • Abiomed Inc Annual Cash Flow from Operations for 2019 was $252m a 23.65% increase of 60m from 2018
  • Abiomed Inc Annual Cash Flow from Operations for 2018 was $193m a 40.21% increase of 77m from 2017
Other Cash Flow Metrics:
  • Abiomed Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $30m a 50.21% increase of 15m year over year
  • Abiomed Inc Total Revenue for the quarter ending December 12, 2018 was $201m a 13.03% increase of 26m year over year
View Chart On Koyfin

Quarterly ABMD Cash Flow from Operations Data

09/2020$77m
06/2020$32m
03/2020$87m
12/2019$89m
09/2019$74m
06/2019$65m
03/2019$70m
12/2018$75m
09/2018$61m
06/2018$47m

Annual ABMD Cash Flow from Operations Data

2020$315m
2019$252m
2018$193m
2017$115m
2016$77m
2015$43m
2014$23m
2013$26m
2012$4m
2011$2m